Section: Pet Parasites

Tick-Borne Illness in Dogs: Comprehensive Review of Common Pathogens and Clinical Syndromes

Introduction

Tick-borne diseases represent a significant and growing challenge in canine veterinary medicine. The geographic expansion of tick vectors, driven by climatic shifts and habitat changes, has increased the exposure of domestic dogs to a diverse array of bacterial, protozoal, and rickettsial pathogens. This review provides a detailed examination of five major tick-borne agents affecting dogs: Anaplasma phagocytophilum, Ehrlichia canis, Babesia canis, Borrelia burgdorferi, and Rickettsia rickettsii. Each pathogen is discussed in terms of its biology, vector ecology, geographic distribution, clinical presentation, diagnostic methodology, and zoonotic potential. The article also presents a diagnostic decision framework to guide clinicians in the workup of suspected tick-borne illness.

Pathogen Profiles

Anaplasma phagocytophilum

Anaplasma phagocytophilum is an obligate intracellular gram-negative bacterium belonging to the family Anaplasmataceae. It primarily infects neutrophils and is transmitted by Ixodes species ticks, particularly Ixodes scapularis in the eastern United States and Ixodes pacificus on the West Coast. The pathogen causes granulocytic anaplasmosis in dogs.

Geographic Distribution. The distribution of A. phagocytophilum mirrors that of its Ixodes vectors. In North America, endemic regions include the Northeast, upper Midwest, and Pacific Northwest. Foci of infection also exist in Europe and Asia.

Clinical Syndromes. The incubation period ranges from 1 to 2 weeks. Clinical signs are often nonspecific and include acute onset fever (often exceeding 39.5 degrees Celsius), lethargy, anorexia, and lameness. Polyarthropathy is a common feature, resulting from immune complex deposition in synovial membranes. Thrombocytopenia is a hallmark laboratory finding, though it is typically mild to moderate. Neutropenia and lymphopenia may also be observed. In severe cases, dogs may develop neurologic signs such as ataxia or seizures, though this is less common.

Diagnostics. Diagnosis relies on a combination of serology and molecular methods. Detection of antibodies via indirect immunofluorescence assay (IFA) or commercial enzyme-linked immunosorbent assay (ELISA) platforms is common. Acute and convalescent serology can demonstrate a fourfold rise in titer. Polymerase chain reaction (PCR) assays targeting the 16S rRNA gene or the msp2 gene are highly sensitive and specific for active infection. Hematologic analysis often reveals thrombocytopenia and mild anemia.

Zoonotic Potential. Anaplasma phagocytophilum is a zoonotic pathogen. Human granulocytic anaplasmosis presents with fever, headache, myalgia, and thrombocytopenia. Dogs serve as sentinel hosts for human infection risk in endemic areas.

Ehrlichia canis

Ehrlichia canis is a gram-negative, obligate intracellular bacterium that infects monocytes and macrophages. It is transmitted primarily by the brown dog tick, Rhipicephalus sanguineus. This pathogen is the causative agent of canine monocytic ehrlichiosis.

Geographic Distribution. Ehrlichia canis has a worldwide distribution but is most prevalent in tropical and subtropical regions. In the United States, it is highly endemic in the southeastern and south-central states, including Texas, Florida, and the Gulf Coast region. The prevalence correlates closely with the distribution of R. sanguineus.

Clinical Syndromes. Canine monocytic ehrlichiosis progresses through three phases: acute, subclinical, and chronic. The acute phase occurs 1 to 3 weeks after tick attachment and is characterized by fever, lethargy, lymphadenomegaly, and thrombocytopenia. The subclinical phase can persist for months to years, during which the dog appears clinically normal but remains seropositive and may harbor the organism. The chronic phase is the most severe and can manifest as pancytopenia, epistaxis, petechiation, and secondary infections due to immunosuppression. Ocular signs, including anterior uveitis and retinal hemorrhages, are common in chronic cases.

Diagnostics. Serologic testing via IFA or ELISA is the primary diagnostic modality. A positive antibody titer indicates exposure, but acute infection may be seronegative. PCR assays targeting the dsb or p30 genes are useful for confirming active infection, particularly in the acute phase. Hematologic findings include thrombocytopenia, leukopenia, and anemia. Hyperglobulinemia is a characteristic finding in chronic ehrlichiosis.

Zoonotic Potential. Ehrlichia canis is not considered a significant zoonotic pathogen. While other Ehrlichia species (e.g., E. chaffeensis) cause human disease, E. canis has only rarely been implicated in human infection.

Babesia canis

Babesia canis is a protozoan parasite of the phylum Apicomplexa that infects erythrocytes. It is transmitted by Dermacentor and Rhipicephalus ticks. The taxonomy of B. canis has been revised, and the species is now divided into subspecies: B. canis canis, B. canis vogeli, and B. canis rossi, each with varying pathogenicity.

Geographic Distribution. Babesia canis vogeli is the most widespread subspecies and is found in tropical and subtropical regions worldwide, including the southern United States. Babesia canis canis is prevalent in Europe. Babesia canis rossi is highly virulent and is restricted to sub-Saharan Africa.

Clinical Syndromes. The clinical severity depends on the subspecies. Babesia canis rossi causes the most severe disease, characterized by hemolytic anemia, hemoglobinuria, fever, icterus, and thrombocytopenia. Babesia canis vogeli typically causes mild to moderate disease, with lethargy, pale mucous membranes, and splenomegaly. Babesia canis canis causes disease of intermediate severity. Complications can include acute renal failure, disseminated intravascular coagulation, and cerebral babesiosis.

Diagnostics. Diagnosis is confirmed by identification of intraerythrocytic merozoites on Giemsa-stained blood smears. This method is sensitive in acute, high-parasitemia cases but may miss low-level infections. PCR assays targeting the 18S rRNA gene are highly sensitive and can differentiate subspecies. Serologic testing via IFA is available but cannot distinguish between active and past infection.

Zoonotic Potential. Babesia canis is not considered zoonotic. Other Babesia species (e.g., B. microti) cause human babesiosis, but B. canis does not infect humans.

Borrelia burgdorferi

Borrelia burgdorferi sensu stricto is a spirochete bacterium and the causative agent of Lyme disease in dogs. It is transmitted by Ixodes species ticks, primarily I. scapularis and I. pacificus in North America.

Geographic Distribution. Lyme disease is highly endemic in the northeastern United States, the upper Midwest, and the Pacific Coast. In Europe, Borrelia afzelii and Borrelia garinii are the predominant genospecies.

Clinical Syndromes. The classic clinical sign in dogs is acute, recurrent lameness due to polyarthropathy. Fever, lethargy, and lymphadenomegaly are common. Unlike in humans, erythema migrans (the "bullseye" rash) is rarely observed in dogs. Renal involvement, termed Lyme nephritis, is a severe complication characterized by protein-losing nephropathy, azotemia, and hypertension. This condition carries a poor prognosis.

Diagnostics. Serologic testing using a two-tier approach is recommended. The first tier involves a quantitative ELISA or a multiplex assay detecting antibodies to the C6 peptide. Positive or equivocal results are confirmed by Western blot (immunoblot) analysis. PCR on blood or synovial fluid is less sensitive due to the low number of spirochetes in the bloodstream. Synovial fluid analysis typically reveals neutrophilic inflammation.

Zoonotic Potential. Borrelia burgdorferi is a significant zoonotic pathogen. Humans develop Lyme disease with characteristic erythema migrans, arthritis, and neurologic manifestations. Dogs are not direct sources of infection for humans but serve as sentinels for tick exposure.

Rickettsia rickettsii

Rickettsia rickettsii is a gram-negative, obligate intracellular bacterium that causes Rocky Mountain spotted fever (RMSF) in dogs and humans. It is transmitted by Dermacentor species ticks, including Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick).

Geographic Distribution. Despite its name, RMSF is most prevalent in the southeastern and south-central United States, including North Carolina, Oklahoma, Arkansas, and Tennessee. Foci also exist in the Rocky Mountain region and parts of Central and South America.

Clinical Syndromes. The incubation period is 2 to 14 days. Clinical signs are acute and severe, including high fever, depression, anorexia, and myalgia. Petechial and ecchymotic hemorrhages on the mucous membranes and skin are characteristic. Neurologic signs such as ataxia, seizures, and stupor can occur. Vasculitis leads to edema of the extremities and face. Thrombocytopenia and hyponatremia are common laboratory findings.

Diagnostics. Diagnosis is challenging due to the rapid progression of disease. Serologic testing via IFA is the mainstay, but antibodies may not be detectable in the first week of illness. PCR on whole blood or skin biopsy specimens can detect R. rickettsii DNA early in the course. Immunohistochemistry on skin biopsies is also diagnostic. Because of the high mortality rate, treatment should be initiated based on clinical suspicion without waiting for laboratory confirmation.

Zoonotic Potential. Rickettsia rickettsii is a highly pathogenic zoonotic agent. Human RMSF is a severe, potentially fatal disease. Dogs are sentinel hosts and can bring infected ticks into the domestic environment.

Comparative Geographic Distribution

The geographic distribution of these pathogens is largely determined by the range of their respective tick vectors. The following table summarizes the primary endemic regions for each pathogen in the United States.

| Pathogen | Primary Vector | Endemic Regions (USA) | | :-, | :-, | :-, | | Anaplasma phagocytophilum | Ixodes scapularis, I. pacificus | Northeast, Upper Midwest, Pacific Coast | | Ehrlichia canis | Rhipicephalus sanguineus | Southeast, South-central states | | Babesia canis (vogeli) | Rhipicephalus sanguineus | Southeast, Gulf Coast | | Borrelia burgdorferi | Ixodes scapularis, I. pacificus | Northeast, Upper Midwest, Pacific Coast | | Rickettsia rickettsii | Dermacentor variabilis, D. andersoni | Southeast, South-central, Rocky Mountain region |

Diagnostic Decision Framework

The clinical workup of a dog with suspected tick-borne illness should integrate signalment, history, physical examination findings, and laboratory data. The following Mermaid diagram outlines a diagnostic decision tree.

flowchart TD
    A[Canine patient with fever, lethargy, lameness, or thrombocytopenia], > B{Recent tick exposure or endemic area?}
    B, Yes, > C[Perform CBC, chemistry panel, and blood smear]
    B, No, > D[Consider other differentials]
    C, > E{Thrombocytopenia present?}
    E, Yes, > F[Serology and PCR for Anaplasma, Ehrlichia, and Rickettsia]
    E, No, > G{Polyarthropathy or lameness?}
    G, Yes, > H[Serology for Borrelia burgdorferi and Anaplasma]
    G, No, > I{Hemolytic anemia or icterus?}
    I, Yes, > J[Blood smear and PCR for Babesia]
    I, No, > K[Consider other tick-borne or non-tick-borne diseases]
    F, > L[Positive PCR or serology?]
    L, Yes, > M[Initiate targeted antimicrobial therapy]
    L, No, > N[Repeat serology in 2-4 weeks if high suspicion]
    H, > O[Positive C6 peptide ELISA?]
    O, Yes, > P[Confirm with Western blot; treat for Lyme disease]
    O, No, > Q[Consider other causes of lameness]
    J, > R[Intraerythrocytic parasites seen or PCR positive?]
    R, Yes, > S[Treat with antiprotozoal agents]
    R, No, > T[Repeat blood smear or PCR if suspicion remains]

Diagnostic Modalities

Serology

Serologic testing detects antibodies produced by the host in response to infection. IFA and ELISA are the most common formats. IFA provides a quantitative titer, while ELISA platforms often provide qualitative or semi-quantitative results. The detection of IgM antibodies indicates recent or acute infection, while IgG antibodies indicate past exposure or chronic infection. A fourfold rise in titer between acute and convalescent samples is considered diagnostic for active infection.

Polymerase Chain Reaction (PCR)

PCR assays detect pathogen DNA in blood, tissue, or synovial fluid. These assays are highly sensitive and specific for active infection. Real-time PCR (qPCR) allows for quantification of pathogen load. PCR is particularly useful in the acute phase before seroconversion has occurred. For Babesia and Ehrlichia, PCR is often the preferred diagnostic method due to its high sensitivity.

Hematology and Biochemistry

Complete blood count (CBC) and serum biochemistry panels provide supportive evidence for tick-borne disease. Thrombocytopenia is a common finding across multiple pathogens. Anemia, leukopenia, and pancytopenia are seen in chronic ehrlichiosis. Hyperglobulinemia is characteristic of chronic E. canis infection. Hyponatremia is a frequent finding in RMSF.

Blood Smear Examination

Giemsa-stained blood smears allow direct visualization of Babesia merozoites within erythrocytes and Anaplasma morulae within neutrophils. This method is rapid and inexpensive but has low sensitivity, particularly in low-parasitemia infections.

Clinical Syndromes Summary

The following table summarizes the key clinical syndromes associated with each pathogen.

| Pathogen | Primary Clinical Syndrome | Key Laboratory Findings | | :-, | :-, | :-, | | Anaplasma phagocytophilum | Polyarthropathy, fever | Thrombocytopenia, neutropenia | | Ehrlichia canis | Monocytic ehrlichiosis (acute, subclinical, chronic) | Thrombocytopenia, pancytopenia, hyperglobulinemia | | Babesia canis | Hemolytic anemia | Anemia, hemoglobinuria, thrombocytopenia | | Borrelia burgdorferi | Lyme arthritis, Lyme nephritis | Neutrophilic synovial fluid, proteinuria | | Rickettsia rickettsii | Rocky Mountain spotted fever | Thrombocytopenia, hyponatremia, vasculitis |

Zoonotic Considerations

Three of the five pathogens discussed have documented zoonotic potential. Borrelia burgdorferi and Anaplasma phagocytophilum are well established causes of human disease in the same geographic regions where canine infections occur. Rickettsia rickettsii is a highly virulent zoonotic agent. Dogs do not directly transmit these pathogens to humans; rather, they serve as sentinel hosts and can carry infected ticks into the home environment. The presence of seropositive dogs in a household indicates a risk of tick exposure for human occupants. Veterinary professionals should counsel clients on tick prevention measures for both pets and people.

Conclusion

Tick-borne illnesses in dogs represent a complex group of diseases caused by phylogenetically diverse pathogens. Accurate diagnosis requires a thorough understanding of the geographic distribution, vector ecology, and clinical presentation of each agent. A combination of serologic and molecular diagnostic methods, interpreted in the context of the patient's history and clinical signs, is essential for appropriate management. The zoonotic potential of several of these agents underscores the importance of a One Health approach to tick-borne disease surveillance and prevention.

References

  1. Little, S. E. (2010). Ehrlichiosis and anaplasmosis in dogs and cats. Veterinary Clinics of North America: Small Animal Practice, 40(6), 1121-1140.
  2. Kidd, L., & Breitschwerdt, E. B. (2003). Transmission times and prevention of tick-borne diseases in dogs. Compendium on Continuing Education for the Practicing Veterinarian, 25(10), 742-751.
  3. Shaw, S. E., Day, M. J., Birtles, R. J., & Breitschwerdt, E. B. (2001). Tick-borne infectious diseases of dogs. Trends in Parasitology, 17(2), 74-80.
  4. Harrus, S., & Waner, T. (2011). Diagnosis of canine monocytotropic ehrlichiosis (Ehrlichia canis): An overview. The Veterinary Journal, 187(3), 292-296.
  5. Solano-Gallego, L., & Baneth, G. (2011). Babesiosis in dogs and cats: Expanding parasitological and clinical spectra. Veterinary Parasitology, 181(1), 48-60.
  6. Littman, M. P., Gerber, B., Goldstein, R. E., Labato, M. A., Lappin, M. R., & Moore, G. E. (2006). ACVIM consensus statement on Lyme disease in dogs: Diagnosis, treatment, and prevention. Journal of Veterinary Internal Medicine, 20(2), 422-434.
  7. Nicholson, W. L., Allen, K. E., McQuiston, J. H., Breitschwerdt, E. B., & Little, S. E. (2010). The increasing recognition of rickettsial pathogens in dogs and people. Trends in Parasitology, 26(4), 205-212.